Anavex Life Sciences Corp (AVXL)

[dia76ca]

Falls can be serious. Interesting that those on placebo had a higher rate of falls than those on drug. And dosing at bed time makes sense as does extended release to level out the dose curve. The patent granted in November 2022 is really interesting. This recent Patent issued by the USPTO "for composition of matter of Anavex 2-73 Blarcamesine A2-73 crystalline polymorph compositions of matter and methods of use thereof" discusses EXTENDED RELEASE (1 to 7 days or more) and a TRANSDERMAL PATCH (1 day to 1 month or more).